Dog Pain Relief Market By Product Type (Pharmaceuticals {Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Anticonvulsants, Others}, Natural & Herbal Remedies {CBD-based Products, Turmeric & Curcumin Formulations, Arnica, Chamomile Extracts, Boswellia}, Nutraceuticals & Supplements {Glucosamine & Chondroitin, Omega-3 Fatty Acids, MSM (Methylsulfonylmethane), Collagen Peptides}, Topical Treatments {Pain Relief Sprays & Gels, Medicated Creams and Lotions, Ointments and Balms}, Medical Devices {Laser Therapy Devices, Acupressure and TENS Units, Orthopedic Braces & Support Devices}), By Pain Type (Acute Pain, Chronic Pain, Neuropathic Pain, Post-Surgical Pain, Osteoarthritis and Joint Pain, Cancer Pain, Injury-related Pain, Others), By Mode of Administration (Oral, Injectable, Topical, Transdermal Patches), By Distribution Channel (Veterinary Clinics, Pet Pharmacies, E-commerce Platforms, Retail Pet Stores, Hospital Pharmacies, Direct-to-Consumer), By End User (Veterinary Hospitals & Clinics, Pet Owners, Animal Rehabilitation Centers, Research & Academic Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035
Published Date: May 2025 | Report ID: MI2848 | 213 Pages
Industry Outlook
The Dog Pain Relief Market accounted for USD 662.76 Million in 2024 and USD 707.30 Million in 2025 and is expected to reach USD 1355.38 Million by 2035, growing at a CAGR of around 6.72% between 2025 and 2035. Dog pain relief is about the different ways we handle and reduce dog pain from conditions including injuries, operations, arthritis, long-term illnesses, and ageing. They include medications, natural remedies, supplements, topical over-the-counter items, and medical devices. The number of people concerned about pet pain has been going up, leading to steady growth in the dog pain relief market. As more dogs are adopted, pets receive better health care and owners grow closer to their pets, it becomes clear that pets require reliable, safe, long-term pain management.
Industry Experts Opinion
“Probably the latest, most important advancement is the understanding that we need to treat pain from multiple perspectives to do the best job for our patients. Old dogs and cats that seem crippled are restored to comfort and function. It’s like a fountain of youth.”
- Dr. Robin Downing – DVM, Dipl. AAPM, Dipl. ACVSMR, Certified Veterinary Pain Practitioner
Report Scope:
Parameter | Details |
---|---|
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Market Size in 2024 | USD 662.76 Million |
CAGR (2025-2035) | 6.72% |
Forecast Years | 2025-2035 |
Historical Data | 2018-2024 |
Market Size in 2035 | USD 1355.38 Million |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa |
What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies. |
Segments Covered | Product Type, Pain Type, Mode of Administration, Distribution Channel, End-user, and Region |
To explore in-depth analysis in this report - Request Sample Report
Market Dynamics
More people are adopting dogs and treating them like family, increasing the demand for pain relief.
The Dog Pain Relief Market is being boosted by more dog adoptions and how pet owners are now caring for them like their own families. Having dogs in their homes, people now better notice and respond to the physical and emotional needs of their pets. Putting their dog’s comfort, wellness, and health is as important to pet parents as it is for other members of the family. If a dog displays signs of being uncomfortable, having pain, or getting older, their owners become more likely to seek out proper care, including relieving their pain. As a result of this change, people now buy more medicines, herbal remedies, supplements, and high-quality pain devices.
Since people are treating their pets as part of the family, they want them to have the same standard of medical care. It means you should bring your pet to the vet regularly, treat painful issues promptly, and supply them with pain medications at the first signs. Lots of pet owners are looking for safe and effective ways to control pain caused by old age, after surgery, or ongoing illnesses. Because people are forming a deeper bond with pets, demand for pain relief drugs is always on the rise. As a consequence, pet healthcare companies are improving their range of products and bringing out new solutions to cope with this rising demand. The increasing view of dogs as part of the family drives both growth and variety in the dog pain relief industry.
New technologies in vet medicine help treat dog pain more effectively.
The Dog Pain Relief Market is being driven by fast progress in veterinary medicine and connected technologies, helping make pain management more accessible and successful. With digital imaging and portable ultrasound machines, veterinarians can identify sources of pain in animals faster and more correctly. Doing so enables doctors to act quickly and give better-targeted care. Long-lasting injections or chewable tablets are new ways of delivering pain medicine, so pet owners and their dogs face less stress when managing pain. As a result of these advances, veterinarians are seeing more effective treatments, which prompts pet owners to seek help more frequently and demand more pain relief.
Modern techniques such as laser treatments, cold therapies, and stem cell therapies are now being offered to help dogs with lasting pain. What was once only used for humans is now also being used in veterinarian care and shows success in dealing with arthritis, injury, or surgical pain. Monitoring your pet’s health at home with wearables and vet tech services helps to spot changes and update treatment as needed after treatment. As prices and availability increase, these technologies allow urban and rural pet owners to use them more easily. Using technology in veterinary medicine is helping ease pain and boosting the market for dog pain relievers, as many owners count on modern care for their pets.Top of Form
Veterinary treatments can be expensive, stopping some owners from getting pain relief for their dogs.
The Dog Pain Relief Market is held back in part by the high vet treatment fees. Sometimes, having surgery on your pet becomes too expensive for most pet owners because of the advanced or costly medical treatments required. Making regular visits to the vet, doing tests, giving medications, and following up can all get expensive fast. Because care is so expensive, many dog owners avoid looking for help, especially when their pet has a lasting health issue that needs frequent treatment. For this reason, some owners may delay or skip treatment for a dog’s discomfort, choosing quick solutions that could have little effect. Because of this, not all unmet needs are met on the market because of the cost factors.
Not offering pet insurance in widespread parts of the world is making things more difficult. Treatment for your pets is not covered by insurance but instead is generally self-paid. It may be a challenge for families whose income isn’t flexible. In parts of the world where veterinary services are scarce, the chance to acquire pain relief products at a low price is much slimmer. Even when veterinary care is advanced, many owners find that new kinds of pain relief, like laser therapy or stem cells, along with specialized supplements, are too expensive for them. Limited finances for many pet owners are slowing down the expansion of the dog pain relief market. With costs still high and insurance not widely accepted, many dogs are unable to receive pain relief, so the market won’t grow quickly.
Non-drug treatments like laser therapy and acupuncture are becoming popular.
Offering laser therapy and acupuncture provides new possibilities in the dog pain relief industry by giving pet owners options that do not involve drugs. A lot of dog owners are turning to natural and safer ways to manage their pets’ chronic conditions, such as arthritis, hip dysplasia, and muscle pain. Laser therapy stimulates the body to repair its cells and boost blood circulation, making it easier to reduce inflammation and promote healing without giving medication. Also, treatment with acupuncture lowers pain and promotes mobility by placing thin needles into certain body points. Because they can help people avoid dangerous drug side effects, these approaches are on the rise. As education about these methods spreads, many veterinary clinics are choosing them, and people can now use mobile pet therapy, too.
These alternatives to drugs draw in pet owners who are interested in keeping their pets well for the long term. If a dog is getting older or dealing with several health issues, owners find that these types of treatments are very beneficial and become their preferred choice for relieving ongoing pain. The trend toward using both traditional and alternative treatments in pets has given the market more service choices. Because of this, businesses can now include medical devices and training sessions for use by vets. As more people ask for personalized natural care, both manufacturers and clinics can come up with new and better solutions for this sector. Awareness campaigns and lower prices for laser therapy and acupuncture can encourage more growth in the dog pain relief market due to today’s pet owners who prefer non-drug solutions.
Telemedicine lets vets check on dogs remotely, making pain care easier.
Telemedicine is providing a major change in the market for dog pain relief because it gives pet owners easier and more flexible ways to access vet help. Pet owners are now able to reach veterinarians using video calls or different online systems, all from home. Since dogs with painful or movement-related problems often find visits to the veterinary clinic distressing or bothersome, this service is highly suitable for them. A vet can review a dog’s health online, give treatment recommendations, and observe how the dog responds, without having to visit in person. Using this method saves pet owners both time and money and makes it easier for vets to respond when symptoms grow worse. Telemedicine is attracting more pet parents who are usually busy and hope to get care for their pets fast without interrupting their day.
Technology helps veterinarians keep track of a pet’s progress and make sure treatment instructions are followed. Pet families can be instructed by vets on how to safeguard their pets from pain via telemedicine. This allows for specialists outside your area to give their opinions, which can make pain treatment better. For communities with few veterinary providers, telemedicine helps more dogs get access to care. With more people learning about telemedicine, such companies can increase the offerings on their platforms and through apps. If these platforms include pain assessment and remote monitoring, providers are better able to offer a complete pain management solution. Not only does this advancement meet what pet owners want, but it is also promoting greater expansion of the dog pain relief market by making professional treatment more available and steady.
Segment Analysis
Based on product type, the Dog Pain Relief Market is segmented into Pharmaceuticals (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Anticonvulsants, Others), Natural & Herbal Remedies (CBD-based Products, Turmeric & Curcumin Formulations, Arnica, Chamomile Extracts, Boswellia), Nutraceuticals & Supplements (Glucosamine & Chondroitin, Omega-3 Fatty Acids, MSM (Methylsulfonylmethane), Collagen Peptides), Topical Treatments (Pain Relief Sprays & Gels, Medicated Creams and Lotions, Ointments and Balms), and Medical Devices (Laser Therapy Devices, Acupressure and TENS Units, Orthopedic Braces & Support Devices). Pharmaceuticals are presently the largest and most influential area in the market. The reason for this is that NSAIDs and corticosteroids act fast and are trusted, so veterinarians often give these drugs to help dogs deal with pain, whether it’s acute or long-lasting. Due to the use of clinical research and strict government regulations, dog owners can count on these products.
You can also buy individual sections of this report.
Would you like to review the price list for each section?
Based on pain type, the Dog Pain Relief Market is segmented into Acute Pain, Chronic Pain, Neuropathic Pain, Post-Surgical Pain, Osteoarthritis and Joint Pain, Cancer Pain, Injury-related Pain, and Others. This category’s largest segment is animal joints because more and more senior and large dogs suffer from joint-related illnesses. Longer life expectancy for pets and higher quality health treatment are making arthritis more frequent, resulting in pet owners wanting to control their pets’ pain for an extended time. Pharmaceutical and nutraceutical advancements have led to a significant increase in growth for this part of the market, helping dogs with pain.
Regional Analysis
The North American dog pain relief market is witnessing steady growth, driven by a high rate of pet ownership and a strong emotional bond between pet parents and their dogs. In this area, many dog owners include their pets in the family and are ready to make their health and comfort a priority. Pets there are well taken care of since vets have the support of advanced medical tools and relief for pain. Many people are looking for prescription drugs, natural remedies, and therapeutic gadgets nowadays. Because of greater recognition of ailments like bone pain and conditions that develop after surgery, there is a greater emphasis on catching these conditions early and keeping pets in pain under control. More people are deciding on professional treatments because pet insurance covers them.
The Asia Pacific dog pain relief market is growing rapidly as awareness about pet health continues to rise. Countries like India, China, Japan, and Australia are seeing more dog adoptions, especially in urban households. Because of this, we are seeing more attention given to veterinary care and items that support pet well-being. Not all markets are fully developed yet, however, the need for easy and efficient pain relief choices is growing. More people in this region enjoy traditional and herbal remedies, which affects their product selections. Because e-commerce is growing, owners of pets now have quick access to many pain relief products through websites. Rising income may mean pet owners consider both regular and unconventional treatments to help their dogs.
Competitive Landscape
Many large and small veterinary medicine companies are part of the Dog Pain Relief Market, all working toward the goal of meeting the growing demand for good pain management treatments for dogs. Five prominent companies in the market, Zoetis Inc., Boehringer Ingelheim, Elanco Animal Health, Merck & Co., and Dechra Pharmaceuticals, offer NSAIDs, opioids, and innovative monoclonal antibody drugs. To give an example, Zoetis' Librela, used to control pain from osteoarthritis in dogs, has become successful in the market, though it has faced questions over possible side effects, which have resulted in renewed warnings and checks from regulators. The market is diverse because Zoetis, Ceva Santé Animale, Norbrook, and Vetoquinol supply a broad selection of pain treatments and therapies. With more importance placed on looking after pets’ health, increased pet ownership, and improvements in veterinary science, companies are motivated to research and release improved ways to treat pain in dogs.
Dog Pain Relief Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Sample Report
Recent Developments:
- In September 2024, Boehringer Ingelheim bought Saiba Animal Health AG as a way to create new treatments for dogs’ chronic ailments.
- In July 2024, Merck Animal Health completed the purchase of Elanco Animal Health Incorporated’s aqua division.
- In March 2024, Zoetis added to its Australian investment by buying a 21-acre factory in Melbourne. This will help the company increase what it does at the site and also prepare for expanding vaccine production and manufacturing for sheep, cattle, dogs, cats, and horses.
Report Coverage:
By Product Type
- Pharmaceuticals
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Opioids
- Corticosteroids
- Anticonvulsants
- Others
- Natural & Herbal Remedies
- CBD-based Products
- Turmeric & Curcumin Formulations
- Arnica
- Chamomile Extracts
- Boswellia
- Nutraceuticals & Supplements
- Glucosamine & Chondroitin
- Omega-3 Fatty Acids
- MSM (Methylsulfonylmethane)
- Collagen Peptides
- Topical Treatments
- Pain Relief Sprays & Gels
- Medicated Creams and Lotions
- Ointments and Balms
- Medical Devices
- Laser Therapy Devices
- Acupressure and TENS Units
- Orthopedic Braces & Support Devices
By Pain Type
- Acute Pain
- Chronic Pain
- Neuropathic Pain
- Post-Surgical Pain
- Osteoarthritis and Joint Pain
- Cancer Pain
- Injury-related Pain
- Others
By Mode of Administration
- Oral
- Injectable
- Topical
- Transdermal Patches
By Distribution Channel
- Veterinary Clinics
- Pet Pharmacies
- E-commerce Platforms
- Retail Pet Stores
- Hospital Pharmacies
- Direct-to-Consumer
By End User
- Veterinary Hospitals & Clinics
- Pet Owners
- Animal Rehabilitation Centers
- Research & Academic Institutions
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
List of Companies:
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
- Merck Animal Health
- Bayer Animal Health
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
- Ceva Santé Animale
- Norbrook Laboratories Limited
- Chanelle Pharma Group Ltd
- SeQuent Scientific Limited
- Assisi Animal Health
- K-Laser USA
- Multi Radiance Medical
- Ourofino Animal Health
Frequently Asked Questions (FAQs)
The Dog Pain Relief Market accounted for USD 662.76 Million in 2024 and USD 707.30 Million in 2025 and is expected to reach USD 1355.38 Million by 2035, growing at a CAGR of around 6.72% between 2025 and 2035.
Key growth opportunities in the Dog Pain Relief Market include non-drug treatments like laser therapy and acupuncture are becoming popular, telemedicine lets vets check on dogs remotely, making pain care easier, and more research is being conducted to develop new and more effective pain relief methods for dogs.
Pharmaceuticals are presently the largest and most influential area in the market. The reason for this is that NSAIDs and corticosteroids act fast and are trusted, so veterinarians often give these drugs to help dogs deal with pain, whether it’s acute or long-lasting.
The Asia Pacific dog pain relief market is growing rapidly as awareness about pet health continues to rise. Countries like India, China, Japan, and Australia are seeing more dog adoptions, especially in urban households.
Key operating players in the Dog Pain Relief Market are Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck Animal Health, Bayer Animal Health, Vetoquinol S.A., etc
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.